Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model.